Comparative efficacy of GLP-1 RAs and SGLT2 inhibitors for prevention of cardiorenal events in type 2 diabetes: a network meta-analysis of cardiovascular outcome trails
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.